PharmGKB Blog
Friday, December 20, 2013

Mixed Results for Genotype-guided Warfarin Dosing - Update

›
Update: New perspective piece from the New England Journal of Medicine The December 12 issue of the New England Journal of Medicine ...
Thursday, December 12, 2013

›
PharmGKB is looking to fill a Scientific Curator position on our team.  Below is a description of the responsibilities of a curator at Pharm...
Thursday, November 21, 2013

Mixed Results for Genotype-guided Warfarin Dosing

›
Update (12/17/2013): New perspective piece from the New England Journal of Medicine The December 12 issue of the New Engl...
Monday, November 18, 2013

Controversy over the PGx of Cisplatin-Induced Hearing Loss in children

›
Hearing loss is a common side effect in cancer patients treated with cisplatin , with significant effects on quality of life. Age, dosage, c...
Thursday, November 14, 2013

PharmGKB Drug Labels: Description, Update and New Features

›
PharmGKB has recently added new information to drug label entries, standardized the annotations, and updated the website display.  The over...

PG&G publication: Mycophenolic acid Pathway

›
Mycophenolic acid (MPA) is an immunosuppressive agent used to prevent rejection in organ transplantation. We recently have published ...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.